CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for therapeutic applications

Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Three decades of messenger RNA vaccine development. Nano Today. 2019;28:100766. https://doi.org/10.1016/j.nantod.2019.100766.

Article 
CAS 

Google Scholar 

Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20:817–38. https://doi.org/10.1038/s41573-021-00283-5.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
…